Home > Name List By other > [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate

CAS No 96829-58-2 , [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl]
(2S)-2-formamido-4-methylpentanoate

  • Name: [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl]
    (2S)-2-formamido-4-methylpentanoate
  • Synonyms: (-)-Tetrahydrolipstatin; Tetrahydrolipstatin;[(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl]
    (2S)-2-formamido-4-methylpentanoate; Alli; Orlipastatum [INN-Latin]; Orlipastat; THLP;Xenical; 96829-58-2;
  • CAS Registry Number:
  • Melting Point: <50 °C
  • Flash Point: 326.3 ºC
  • Boiling Point: 615.9 ºC at 760 mmHg
  • Density: 0.976 g/cm3
  • Refractive index: 1.469
  • Water Solubility: DMSO: 19 mg/mL in water
  • Flash Point: 326.3 ºC
  • Molecular Weight: 495.73482
  • InchiKey: AHLBNYSZXLDEJQ-FWEHEUNISA-N
  • InChI: InChI=1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-
    31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h22-27H,5-21H2,1-4H3,
    (H,30,31)/t24-,25-,26-,27-/m0/s1
  • Molecular Formula: C29H53NO5
  • Molecular Structure:CAS No:96829-58-2 [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl]<br />(2S)-2-formamido-4-methylpentanoate
Search by region :

Select to

96829-58-2 Orlistat

Contact Supplier

96829-58-2 Orlistat

Contact Supplier

96829-58-2 Orlistat

  • China Wuxi Mizat Chemical Technology Co., Ltd. [Manufacturer]
  • Tel: +86-510-86106900/ +86-510-86125752
  • Fax: +86-510-86125752
  • Address: No.205,zhencheng Road,
    HI-TECT District,
    Wuxi, Jiangsu,China null,nullChina
Contact Supplier

96829-58-2 Orlistat

  • China Boronsyn Co.,Ltd [Manufacturer]
  • Tel: +86-21-58407925
  • Fax: +86-21-58408291
  • Address: 1213 JunMin Road,Pudong,China null,nullChina
Contact Supplier

96829-58-2 Orlistat

  • China Kouting Chemical Co.,Ltd [Importer/Exporter]
  • Tel: +86-(21)-58116473
  • Fax: +86-(21)-61094103
  • Address: Hunan Road, Pudong New District, Shanghai, Shanghai 201318, shanghai,shanghaiChina
Contact Supplier

96829-58-2 Orlistat

Contact Supplier

96829-58-2 Orlistat

  • China Shanghai chemrole co.,ltd [Manufacturers]
  • Tel: 021-50278900
  • Fax: 021-50278968
  • Address: No.6,bisheng road ,shanghai ,china null,ShanghaiChina
Contact Supplier

96829-58-2 ORLISTAT

  • India JAI RADHE SALES null
  • Fax: 0091-79-26569884
  • Address: 309/310 HARIKRUPA TOWER,NR.OLD SHARDA MANDIR CHAR RASTA,ELLISBRIDGE ,AHMEDABAD,GUJRAT , INDIA. null,nullIndia
Contact Supplier

96829-58-2 Orlistat

  • China Xilin Chemical Group Co., Ltd null
  • Tel: +86-(0)-15527136576
  • Fax: +86-(27)-83820093
  • Address: 16# Luojiashan, Wuchang District, Wuhan, Hubei 430071, null,nullChina
Contact Supplier

96829-58-2 Orlistat

  • China Ruiyuan Group Limited [Manufacturers]
  • Tel: +86-21-50456736
  • Fax: +86-21-60853441
  • Address: No.188, Zhangyang Road, Pudong, Shanghai 200122, null,nullChina
Contact Supplier

Select to

References of [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl]
(2S)-2-formamido-4-methylpentanoate
Title: Orlistat
CAS Registry Number: 96829-58-2
CAS Name: N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester
Synonyms: N-formyl-L-leucine ester with (3S,4S)-3-hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone; (-)-tetrahydrolipstatin; orlipastat
Manufacturers' Codes: Ro-18-0647
Trademarks: Xenical (Hoffmann-La Roche)
Molecular Formula: C29H53NO5
Molecular Weight: 495.73
Percent Composition: C 70.26%, H 10.78%, N 2.83%, O 16.14%
Literature References: Pancreatic lipase inhibitor. Isoln from fermentation broth of Streptomyces toxytricini: P. Hadvary et al., EP 129748; eidem, US 4598089 (1985, 1986 both to Hoffmann-LaRoche). Structural elucidation: E. Hochuli et al., J. Antibiot. 40, 1086 (1987). Synthesis and absolute configuration: P. Barbier, F. Schneider, Helv. Chim. Acta 70, 196 (1987). Total synthesis: S. Hanessian et al., J. Org. Chem. 58, 7768 (1993). Mechanism of action: B. Borgstr?m, Biochim. Biophys. Acta 962, 308 (1988). Clinical pharmacology: J. B. Hauptman et al., Am. J. Clin. Nutr. 55, 309S (1992). Clinical trial: M. H. Davidson et al., J. Am. Med. Assoc. 281, 235 (1999). Review of pharmacology and clinical efficacy in treatment of obesity: W. McNeely, P. Benfield, Drugs 56, 241-249 (1998). Evaluation of long-term efficacy and tolerability: J. Hauptman et al., Arch. Fam. Med. 9, 160 (2000).
Properties: Crystals, mp 43°. [a]D20 -32.0° (c = 1 in chloroform).
Melting point: mp 43°
Optical Rotation: [a]D20 -32.0° (c = 1 in chloroform)
Therap-Cat: Antiobesity agent.
Keywords: Antiobesity Agent.